Bio-Rad Laboratories Inc. BIO
Super Investor & Insider
3
Fondi che lo detengono
#259
Rank consenso
4.3%
% dei portafogli
$990.0M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| First Eagle Investment Management · First Eagle Investment Management | 1.23% | Add 1.26% | 2,602,772 | $725.5M |
| John Rogers · Ariel Investments | 2.45% | Add 2.78% | 785,961 | $219.1M |
| Mason Hawkins · Southeastern Asset Management | 2.23% | Reduce 28.48% | 162,804 | $45.4M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Bio-Rad Laboratories, Inc. develops, manufactures, and markets specialized products for the clinical diagnostics and life sciences markets. In clinical diagnostics, the company provides test systems and quality control solutions for clinical laboratories. In life sciences, it produces instruments and reagents for resea…
SectorHealthcare
ExchangeNYSE
IndustryMedical Devices
CountryUnited States
Employees7,450
TickerBIO
Statistics
Market Cap$7.64B
Revenue (TTM)$2.58B
Net Income$759.9M
Net Margin29.4%
EPS$27.85
P/E48.58
P/S3.02
P/B1.15
EV/EBITDA17.09
ROE2.5%
Dividend Yield—
Price$284.69
Data: Twelve Data · Revenue = mcap / P/S